The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
Dive Brief: Hospitals enrolled in the 340B drug discount program may no longer be eligible after the pandemic shifted their payer mix, according to a Wednesday letter the American Hospital Association sent to HHS Secretary Xavier Becerra. Depleted patient volumes and canceled elective surgeries lowered the proportion of hospital patients who are Medicaid and Medicare… Read More »
As detailed in “Spy Agencies Threaten to ‘Take Out’ Mercola,” this website has been labeled a national security threat by British and American intelligence agencies that are collaborating to eliminate “anti-vaccine propaganda” from public discussion using sophisticated cyberwarfare tools.1,2,3 One of the public frontrunners in this comprehensive attack on my freedom of speech is a… Read More »
A general view of the Centers for Disease Control and Prevention Edward R. Roybal campus in Atlanta, Georgia on April 23, 2020. Tami Chappell | AFP | Getty Images With some school districts just weeks away from the start of the academic year, the Centers for Disease Control and Prevention released long-awaited guidelines for reopening with a… Read More »
The purpose of the United Nations, as it defines it, is the “maintenance of international peace and security.” But the U.N. has interpreted this mission statement in a way that justifies all sorts of international intrusions, whether that means forcing developing countries to use less energy, launching its own kind of social justice campaign across… Read More »